Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines

This publication has 17 references indexed in Scilit:

• Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
  Vaccine, 2007
• Enhanced growth of seed viruses for H5N1 influenza vaccines
  Virology, 2007
• Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
  Vaccine, 2005
• The role of cell culture vaccines in the control of the next influenza pandemic
  Expert Opinion on Biological Therapy, 2004
• Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use
  Virus Research, 2004
• Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
  Medical Microbiology and Immunology, 2002
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
  The Lancet, 2001
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
  Vaccine, 2001
• Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
  Vaccine, 1998
• An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines
  Journal of Biological Standardization, 1977